Activation of the type I interferon pathway in primary Sjogren's syndrome

Journal of Autoimmunity

Volumn 35, Issue 3, 2010, Pages 225-231

  Mavragani, Clio P ^a   Crow, Mary K ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

Pathogenesis; Sjogren's syndrome; Type I interferon

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 1; CYTIDINE DEAMINASE; INTERFERON; INTERFERON REGULATORY FACTOR 5; STAT4 PROTEIN;

ARTICLE; B LYMPHOCYTE; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; EPIGENETICS; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; INTERFERON PRODUCTION; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METHYLATION; SALIVARY GLAND BIOPSY; SIGNAL TRANSDUCTION; SJOEGREN SYNDROME;

EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERFERON REGULATORY FACTORS; INTERFERON TYPE I; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MIDDLE AGED; POLYMORPHISM, GENETIC; SALIVARY GLANDS; SIGNAL TRANSDUCTION; SJOGREN'S SYNDROME; STAT4 TRANSCRIPTION FACTOR;

EID: 77957768966     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2010.06.012     Document Type: Article

References (63)

1. Mavragani C.P., Moutsopoulos H.M. The geoepidemiology of Sjogren's syndrome. Autoimmun Rev 2010, 9(5):A305-A310.
2. Mavragani C.P., Skopouli F.N., Moutsopoulos H.M. Increased prevalence of antibodies to thyroid peroxidase in dry eyes and mouth syndrome or sicca asthenia polyalgia syndrome. J Rheumatol 2009, 36:1626-1630.
3. Manoussakis M.N., Kapsogeorgou E.K. The role of epithelial cells in the pathogenesis of Sjogren's syndrome. Clin Rev Allergy Immunol 2007, 32:225-230.
4. Skopouli F.N., Moutsopoulos H.M. Autoimmune epitheliitis: Sjogren's syndrome. Clin Exp Rheumatol 1994, 12(Suppl. 11):S9-11.
5. Triantafyllopoulou A., Moutsopoulos H. Persistent viral infection in primary Sjogren's syndrome: review and perspectives. Clin Rev Allergy Immunol 2007, 32:210-214.
6. Kirou K.A., Mavragani C.P., Crow M.K. Activation of type I interferon in systemic lupus erythematosus. Exp Rev Clin Immunol 2007, 3:579-588.
7. Kim Y.M., Brinkmann M.M., Paquet M.E., Ploegh H.L. UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature 2008, 13(452):234-238.
8. Lande R., Gilliet M. Plasmacytoid dendritic cells: key players in the initiation and regulation of immune responses. Ann N Y Acad Sci 2010, 1183:89-103. Review.
9. Choubey D., Duan X., Dickerson E., Ponomareva L., Panchanathan R., Shen H., et al. Interferon-inducible p200-family proteins as novel sensors of cytoplasmic DNA: role in inflammation and autoimmunity. J Interferon Cytokine Res 2010 Feb 28.
10. Meyer O. Interferons and autoimmune disorders. Joint Bone Spine 2009, 76:464-473.
11. Meller S., Winterberg F., Gilliet M., Muller A., Lauceviciute I., Rieker J., et al. Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: An amplification cycle triggering cutaneous lupus erythematosus. Arthritis Rheum 2005, 52:1504-1516.
12. Denny M.F., Thacker S., Mehta H., Somers E.C., Dodick T., Barrat F.J., et al. Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis. Blood 2007, 110:2907-2915.
13. Perl A. Emerging new pathways of pathogenesis and targets for treatment in systemic lupus erythematosus and Sjogren's syndrome. Curr Opin Rheumatol 2009, 21:443-447.
14. Gottenberg J.E., Cagnard N., Lucchesi C., Letourneur F., Mistou S., Lazure T., et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome. Proc Natl Acad Sci U S A 2006, 103:2770-2775.
15. Hjelmervik T.O., Petersen K., Jonassen I., Jonsson R., Bolstad A.I. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects. Arthritis Rheum 2005, 52:1534-1544.
16. Ittah M., Miceli-Richard C., Eric Gottenberg J., Lavie F., Lazure T., Ba N., et al. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjogren's syndrome. Arthritis Res Ther 2006, 8:R51.
17. Emamian E.S., Leon J.M., Lessard C.J., Grandits M., Baechler E.C., Gaffney P.M., et al. Peripheral blood gene expression profiling in Sjögren's syndrome. Genes Immun 2009, 10:285-296.
18. Hua J., Kirou K., Lee C., Crow M.K. Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies. Arthritis Rheum 2006, 54:1906-1916.
19. Zheng L., Zhang Z., Yu C., Tu L., Zhong L., Yang C. Association between IFN-alpha and primary Sjogren's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009, 107(1):e12-e18.
20. Wildenberg M.E., van Helden-Meeuwsen C.G., van de Merwe J.P., Drexhage H.A., Versnel M.A. Systemic increase in type I interferon activity in Sjogren's syndrome: a putative role for plasmacytoid dendritic cells. Eur J Immunol 2008, 38:2024-2033.
21. Hooks J.J., Moutsopoulos H.M., Geis S.A., Stahl N.I., Decker J.L., Notkins A.L. Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med 1979, 301:5-8.
22. Niewold T.B., Rivera T.L., Buyon J.P., Crow M.K. Serum type I interferon activity is dependent on maternal diagnosis in anti-SSA/Ro-positive mothers of children with neonatal lupus. Arthritis Rheum 2008, 58:541-546.
23. Mavragani C.P., Niewold T.B., Moutsopoulos N.M., Pillemer S.R., Wahl S.M., Crow M.K. Augmented interferon-α pathway activation in patients with Sjogren's syndrome treated with etanercept. Arthritis Rheum 2007, 56:3995-4004.
24. Båve U., Nordmark G., Lövgren T., Rönnelid J., Cajander S., Eloranta M.L., et al. Activation of the type I interferon system in primary Sjogren's syndrome: a possible etiopathogenic mechanism. Arthritis Rheum 2005, 52:1185-1195.
25. Vogelsang P., Brun J.G., Oijordsbakken G., Skarstein K., Jonsson R., Appel S. Levels of plasmacytoid dendritic cells and type-2 myeloid dendritic cells are reduced in peripheral blood of patients with primary Sjogren's syndrome. Ann Rheum Dis 2009 Nov 12.
26. Farkas L., Beiske K., Lund-Johansen F., Brandtzaeg P., Jahnsen F.L. Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am J Pathol 2001, 159:237-243.
27. López de Padilla C.M., Vallejo A.N., McNallan K.T., Vehe R., Smith S.A., Dietz A.B., et al. Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis. Arthritis Rheum 2007, 56:1658-1668.
28. Deshmukh U.S., Nandula S.R., Thimmalapura P.R., Scindia Y.M., Bagavant H. Activation of innate immune responses through Toll-like receptor 3 causes a rapid loss of salivary gland function. J Oral Pathol Med 2009, 38:42-47.
29. Spachidou M.P., Bourazopoulou E., Maratheftis C.I., Kapsogeorgou E.K., Moutsopoulos H.M., Tzioufas A.G., et al. Expression of functional Toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjögren's syndrome. Clin Exp Immunol 2007, 147:497-503.
30. Bave U., Alm G.V., Ronnblom L. The combination of apoptotic U937 cells and lupus IgG is a potent IFN-alpha inducer. J Immunol 2000, 165:3519-3526.
31. Crow M.K. Interferon-alpha: a therapeutic target in systemic lupus erythematosus. Rheum Dis Clin North Am 2010, 36:173-186.
32. Strandberg L., Ambrosi A., Espinosa A., Ottosson L., Eloranta M.L., Zhou W. Interferon-alpha induces upregulation and nuclear translocation of the Ro52 autoantigen as detected by a panel of novel Ro52-specific monoclonal antibodies. J Clin Immunol 2008, 28:220-231.
33. Espinosa A., Dardalhon V., Brauner S., Ambrosi A., Higgs R., Quintana F.J., et al. Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway. J Exp Med 2009, 206:1661-1671.
34. Krapf F.E., Herrmann M., Leitmann W., Kalden J.R. Are retroviruses involved in the pathogenesis of SLE? Evidence demonstrated by molecular analysis of nucleic acids from SLE patients' plasma. Rheumatol Int 1989, 9:115-121.
35. Li J.Z., Steinman C.R. Plasma DNA in systemic lupus erythematosus. characterization of cloned base sequences. Arthritis Rheum 1989, 32:726-733.
36. Steinman C.R. Circulating DNA in systemic lupus erythematosus. Isolation and characterization. J Clin Invest 1984, 73:832-841.
37. Steinman C.R. Circulating DNA-containing immune complexes in SLE. J Immunol 1983, 130:1990-1991.
38. Crow M.K. Long interspersed nuclear elements (LINE-1): potential triggers of systemic autoimmune disease. Autoimmunity 2010, 43:7-16.
39. Mavragani C.P., Kapsogeorgou E., Pierce D., Seshan S., Moutsopoulos H.M., Crow M.K. Endogenous LINE-1 (L1) retrotransposon elements: candidate triggers of Type I Interferon (IFN) production in autoimmune disorders. Arthritis Rheum 2007, 56:S630.
40. Bestor T.H. The DNA methyltransferases of mammals. Hum Mol Genet 2000, 9:2395-2402.
41. Liang G., Chan M.F., Tomigahara Y., Tsai Y.C., Gonzales F.A., Li E., et al. Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements. Mol Cell Biol 2002, 22:480-491.
42. Hansen R.S. X inactivation-specific methylation of LINE-1 elements by DNMT3B: implications for the Lyon repeat hypothesis. Hum Mol Genet 2003, 12:2559-2567.
43. Yu F., Zingler N., Schumann G., Stratling W.H. Methyl-CpG-binding protein 2 represses LINE-1 expression and retrotransposition but not Alu transcription. Nucleic Acids Res 2001, 29:4493-4501.
44. Bogerd H.P., Wiegand H.L., Doehle B.P., Lueders K.K., Cullen B.R. APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells. Nucleic Acids Res 2006, 34:89-95.
45. Chen H., Lilley C.E., Yu Q., Lee D.V., Chou J., Narvaiza I., et al. APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons. Curr Biol 2006, 16:480-485.
46. Stenglein M.D., Harris R.S. APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism. J Biol Chem 2006, 281:16837-16841.
47. Hamilton C.E., Papavasiliou F.N., Rosenberg B.R. Diverse functions for DNA and RNA editing in the immune system. RNA Biol 2010, 7(2). [Epub ahead of print] PubMed PMID: 20220309.
48. Mavragani C.P., Moffit K., Kapsogeorgou E.K., Moutsopoulos H.M., Crow M.K. Coordinate expression of defensive regulators of L1 endogenous retroelements in primary Sjogren's syndrome. Arthritis Rheum 2007, 56:S542.
49. Ioannidis J.P., Vassiliou V.A., Moutsopoulos H.M. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren's syndrome. Arthritis Rheum 2002, 46:741-747.
50. Richardson B. Primer: epigenetics of autoimmunity. Nat Clin Pract Rheumatol 2007, 3:521-527.
51. Schumacher A., Petronis A. Epigenetics of complex diseases: from general theory to laboratory experiments. Curr Top Microbiol Immunol 2006, 310:81-115.
52. Crow M.K. Collaboration, genetic associations, and lupus erythematosus. N Engl J Med 2008, 358:956-961.
53. Kariuki S.N., Niewold T.B. Genetic regulation of serum cytokines in systemic lupus erythematosus. Transl Res. 2010 Mar, 155(3):109-117.
54. Jonsson R., Bolstad A.I., Brokstad K.A., Brun J.G. Sjogren's syndrome-a plethora of clinical and immunological phenotypes with a complex genetic background. Ann NY Acad Sci 2007, 1108:433-447.
55. Korman B.D., Alba M.I., Le J.M., Alevizos I., Smith J.A., Nikolov N.P., et al. Variant form of STAT4 is associated with primary Sjogren's syndrome. Genes Immun 2008, 9:267-270.
56. Miceli-Richard C., Comets E., Loiseau P., Puechal X., Hachulla E., Mariette X. Association of an IRF5 gene functional polymorphism with Sjogren's syndrome. Arthritis Rheum 2007, 56:3989-3994.
57. Miceli-Richard C., Gestermann N., Ittah M., Comets E., Loiseau P., Puechal X., et al. The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjögren's syndrome. Arthritis Rheum 2009, 60:1991-1997.
58. Nordmark G., Kristjansdottir G., Theander E., Eriksson P., Brun J.G., Wang C., et al. Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjögren's syndrome. Genes Immun 2009, 10:68-76.
59. Mamtani M., Anaya J.M., He W., Ahuja S.K. Association of copy number variation in the FCGR3B gene with risk of autoimmune diseases. Genes Immun 2009.
60. Ansari A.A., Gershwin M.E. Navigating the passage between Charybdis and Scylla: recognizing the achievements of Noel Rose. J Autoimmun 2009, 33:165-169.
61. Whittingham S., Rowley M.J., Gershwin M.E. A tribute to an outstanding immunologist - Ian Reay Mackay. J Autoimmun 2008, 31:197-200.
62. Gershwin M.E. Bone marrow transplantation, refractory autoimmunity and the contributions of Susumu Ikehara. J Autoimmun 2008, 30:105-107.
63. Gershwin M.E. The mosaic of autoimmunity. Autoimmun Rev 2008, 7:161-163.